trending Market Intelligence /marketintelligence/en/news-insights/trending/kC4XNB4xL_EKNCGL-iWqHg2 content esgSubNav
In This List

NovaBay stockholders approve $10.3M stock financing

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


NovaBay stockholders approve $10.3M stock financing

NovaBay Pharmaceuticals Inc.'s stockholders approved the issue of 2.4 million shares of common stock worth $10.32 million to Ch-gemstone Capital (Beijing) Co. Ltd.

The vote took place at a special meeting of stockholders held Dec. 20.

The private placement is expected to close in January 2018, subject to customary closing conditions, including approval for funds transfer by the applicable regulatory authorities in China.

The company plans to use the funds to advance the growth strategy for its eye care product, Avenova.